Evidence map›Paper›PMID 19837085›Full record

ArticleJournal of molecular biology2010

Role of small oligomers on the amyloidogenic aggregation free-energy landscape.

Xianglan He, Jason T Giurleo, David S Talaga

Abstract read
In one paragraph

Article in Journal of molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The role of initial oligomers in amyloid fibril formation by human stefin B.International journal of molecular sciences · 2013
    Article
  7. Molecular mechanism of misfolding and aggregation of Aβ(13-23).The journal of physical chemistry. B · 2013
    Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xianglan HeDepartment of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Jason T Giurleo
David S Talaga

Funding

New statistical tools for single molecule experimentsR01GM071684 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI TALAGA, DAVID S · 2004 to 2010
$1.2M
NIGMS NIH HHS R01 GM071684NIGMS NIH HHS R01GM071684
6 · The paper itself

Abstract

We combine atomic-force-microscopy particle-size-distribution measurements with earlier measurements on 1-anilino-8-naphthalene sulfonate, thioflavin T, and dynamic light scattering to develop a quantitative kinetic model for the aggregation of beta-lactoglobulin into amyloid. We directly compare our simulations to the population distributions provided by dynamic light scattering and atomic force microscopy. We combine species in the simulation according to structural type for comparison with fluorescence fingerprint results. The kinetic model of amyloidogenesis leads to an aggregation free-energy landscape. We define the roles of and propose a classification scheme for different oligomeric species based on their location in the aggregation free-energy landscape. We relate the different types of oligomers to the amyloid cascade hypothesis and the toxic oligomer hypothesis for amyloid-related diseases. We discuss existing kinetic mechanisms in terms of the different types of oligomers. We provide a possible resolution to the toxic oligomer-amyloid coincidence.

Indexed as

AmyloidAnilino NaphthalenesulfonatesAnimalsCattleComputer SimulationKineticsLactoglobulinsLightMicroscopy, Atomic ForceModels, ChemicalProtein Structure, QuaternaryReproducibility of ResultsScattering, RadiationThermodynamicsTime Factors1-anilino-8-naphthalenesulfonateAmyloidAnilino NaphthalenesulfonatesLactoglobulins

Identifiers

PMID19837085
PMCPMC2801572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.